Tindara Previtera
University of Messina
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tindara Previtera.
European Journal of Medicinal Chemistry | 1994
Tindara Previtera; Mg Vigorita; M Basile; F Orsini; Franco Benetollo; Gabriella Bombieri
Abstract The stereochemistry of the 3,3′-(1,2-ethanediyl)bis[2-(3-fluorophenyl)-1,3-thiazolidine-4-one] configurational isomers ( 2R,2′R 2S,2′ S and 2R,2′S meso ) has been investigated by 1 H-NMR techniques in solution, by X-ray diffraction methods in the solid state and by quantum chemical methods as the free molecule. The racemic compound, which has antagonistic activity at both H 1 and H 2 receptors, is found to prefer a gauche conformation in CDCl 3 solution, in the solid state and in the free molecule. The inactive meso stereoisomer is centrosymmetric in the crystalline state with an antiperiplanar conformation of the ethylene chain, whereas in CDCl 3 solution it exists as a rapidly interconverting mixture of 3 rotamers. The free molecule presents 2 gauche and 1 anti -periplanar conformations (differing by 1.3–2.4 kcal/mol). Some relationships between stereochemistry and activity are discussed.
European Journal of Medicinal Chemistry | 1987
Tindara Previtera; Maria Basile; Maria Gabriella Vigorita; G. Fenech; Francesco Occhiuto; C. Circosta; Rita De Pasquale
Abstract In pursuing our search on anti-inflammatory dl and meso 3,3′-di[1,3-thiazolidine-4-one] compounds, two series of derivatives have been prepared by modifying the substitution pattern at positions 1 and 2 of the heterocyclic rings and by introducing an ethylene chain between nitrogen atoms. The anti-inflammatory activity of these compounds has been preliminarily assayed against carrageenin-induced rat paw edema: those proven to be active were also tested for analgesic, anti-pyretic and anti-histamine properties. As a whole, the obtained results suggest that some of the new derivatives possess significant anti-histamine activity. The meso forms generally are more active than dl ones in agreement with the previously emphasized SAR of the chiral systems under study.
European Journal of Medicinal Chemistry | 1990
Tindara Previtera; Maria Gabriella Vigorita; M Basile; G. Fenech; A Trovato; Francesco Occhiuto; Mt Monforte; R Barbera
A class of anti-inflammatory, analgesic and histamine H1- and H2-receptor antagonists the 2,2′-diheteroarylbisthiazolidinones and their 1,1′-disulfones, obtained as [RR, SS] and [RS, SR] isomers, is described. The heteroaryl substitution at 2 and 2′ carbons generally improves the pharmacological activities with respect to those of the previously studied 2,2′-diaryl analogues. In particular the 2,2′-dithienyl derivatives exhibit analgesic properties and, as [RS, SR] isomers 6b, 11b, 12b H2-histamine receptor antagonism as well. The most effective acute anti-inflammatory agents appear to be the 2,2′-di(3-pyridyl) compounds 8a, 8b, 14a, 14b which also display analgesic activity. Moreover, an H1-histamine receptor antagonism is almost selectively exerted by the 2,2′-di(2-pyridyl) derivatives 7a, 7b, 13a, 13b. The relationships between the assessed activities and the chirality and/or the sulfur oxidation state of the molecules are discussed. The anti-cancer potential was also evaluated against P 388 murine lymphocytic leukemia; however, the results were not significant.
Journal of Chromatography A | 1995
Salvatore Caccamese; Grazia Principato; Rosaria Ottanà; Tindara Previtera; Carmela Zappalà
Abstract The enantiomers of anti-inflammatory and antihistaminic 3,3′-(1,2-ethanediyl)bis(2-aryl-1,3-thiazolidin-4-one) derivatives possessing two stereogenic centres were separated on Chiralcel OD stationary phase without derivatization. The meso form was also well separated from the enantiomers. The good resolution afforded a milligram-scale separation and subsequent measurement of the circular dichroism spectra of an enantiomeric pair. Addition of racemic α-mercaptopropionic acid to the N,N′-dibenzylideneethylenediamine yielded ten possible stereoisomers with four stereogenic centres. Two centres (2 and 2′) bear the same groups; the other two (5 and 5′) also bear the same groups, but these are different from the groups at 2 and 2′. In this situation four enantiomeric pairs and two meso forms exist; all of them were separated and identified using a Chiralpak AD column.
Journal of Chemical Crystallography | 1995
Fulvia Orsini; Gabriella Bombieri; Franco Benetollo; M. Gabriella Vigorita; Tindara Previtera
Abstract3,3′(1,2-Ethanediyl)bis(2-halophenyl-thiazolidin-4-one) derivatives display different pharmacological activities depending on the configuration of the 2,2′ centers and on the oxidation state of the sulfur atoms. Quantum-chemical calculations on the 3-fluorophenyl-substituted configurational isomers are reported here, together with the X-ray structure of the 1∶1 dioxide derivative. This crystallizes in the monoclinic space group P21/c, with four molecules per unit cell and cell dimensions:a=18.917(3),b=9.003(2),c=12.062(2)Å, β=96.20(3)°. The compound, which has an approximate center of symmetry in the middle of the ethylene chain and two asymmetric carbon atoms of opposite chiralities, is the (2R,2′S-meso) (or 2S,2′R-meso) stereoisomer.
Journal of Molecular Structure | 1998
Franco Benetollo; Gabriella Bombieri; A. Del Pra; F. Orsini; Tindara Previtera; M.G. Vigorita
Abstract 3,3′-(1,2-ethanediyl)bis[2-substituted-1,3-thiazolidin-4-one] derivatives display different biological activities depending on the configuration of the 2,2′ centers and on the substitution at C2, C2′. In this context, 3,3′-(1,2-ethanediyl)bis[2-(2′-(5′-methyl)thienyl)-1,3-thiazolidin-4-one] ( 6b ) and 3,3′-(1,2-ethanediyl)bis[2-(3′-pyridyl)-1,3-thiazolidin-4-one] ( 8b ) have been prepared. Their structural and conformational features, which can be related to the biological activity, have been investigated by X-ray diffraction and molecular modeling techniques.
Journal of Chemical Crystallography | 1991
Franco Benetollo; Gabriella Bombieri; A. Del Pra; M. Basile; Tindara Previtera; M.G. Vigorita
European Journal of Medicinal Chemistry | 1987
Tindara Previtera
European Journal of Medicinal Chemistry | 1990
Tindara Previtera
Acta Crystallographica Section C-crystal Structure Communications | 1990
Franco Benetollo; G. Bombieri; A. Del Pra; M. Basile; Tindara Previtera; M.G. Vigorita